DK4393545T3 - Hidtil ukendte anvendelser af piperidinyl-indolderivater - Google Patents

Hidtil ukendte anvendelser af piperidinyl-indolderivater

Info

Publication number
DK4393545T3
DK4393545T3 DK24170648.0T DK24170648T DK4393545T3 DK 4393545 T3 DK4393545 T3 DK 4393545T3 DK 24170648 T DK24170648 T DK 24170648T DK 4393545 T3 DK4393545 T3 DK 4393545T3
Authority
DK
Denmark
Prior art keywords
indole derivatives
piperidinyl
unknown uses
unknown
piperidinyl indole
Prior art date
Application number
DK24170648.0T
Other languages
English (en)
Inventor
Jörg Eder
Richard Alexander Harrison
Boerje Haraldsson
Anna Svenja Schubart
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK4393545T3 publication Critical patent/DK4393545T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK24170648.0T 2017-08-31 2018-08-30 Hidtil ukendte anvendelser af piperidinyl-indolderivater DK4393545T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17188870 2017-08-31
EP18769510.1A EP3675854B1 (en) 2017-08-31 2018-08-30 Piperidinyl-indole derivatives for use in the treatment of c3 glomerulopathy

Publications (1)

Publication Number Publication Date
DK4393545T3 true DK4393545T3 (da) 2026-01-12

Family

ID=59745840

Family Applications (2)

Application Number Title Priority Date Filing Date
DK18769510.1T DK3675854T3 (da) 2017-08-31 2018-08-30 Piperidinyl-indolderivativer til anvendelse ved behandling af c3-glomerulopati
DK24170648.0T DK4393545T3 (da) 2017-08-31 2018-08-30 Hidtil ukendte anvendelser af piperidinyl-indolderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK18769510.1T DK3675854T3 (da) 2017-08-31 2018-08-30 Piperidinyl-indolderivativer til anvendelse ved behandling af c3-glomerulopati

Country Status (22)

Country Link
US (3) US11723901B2 (da)
EP (3) EP4393545B1 (da)
JP (3) JP6754919B1 (da)
KR (3) KR102682887B1 (da)
CN (5) CN117398384A (da)
AU (1) AU2018326768B2 (da)
BR (1) BR112020003737A2 (da)
CA (1) CA3073346A1 (da)
CL (1) CL2020000483A1 (da)
DK (2) DK3675854T3 (da)
ES (2) ES3058507T3 (da)
FI (2) FI4393545T3 (da)
HR (2) HRP20250386T1 (da)
HU (1) HUE071118T2 (da)
IL (1) IL272888B2 (da)
LT (2) LT3675854T (da)
MX (3) MX2020002185A (da)
PL (2) PL4393545T3 (da)
PT (2) PT4393545T (da)
RS (2) RS66635B1 (da)
SI (2) SI3675854T1 (da)
WO (1) WO2019043609A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS66635B1 (sr) 2017-08-31 2025-04-30 Novartis Ag Derivati piperidinil-indola za upotrebu u lečenju c3 glomerulopatije
TWI895316B (zh) * 2019-12-19 2025-09-01 日商大鵬藥品工業股份有限公司 以縮合嘧啶化合物作為有效成分之治療劑
CN120208923A (zh) 2020-05-18 2025-06-27 诺华股份有限公司 Lnp023的结晶形式
WO2022028507A1 (zh) 2020-08-07 2022-02-10 上海美悦生物科技发展有限公司 一种杂环类化合物、其制备方法及用途
KR20230049115A (ko) * 2020-08-07 2023-04-12 상하이 메이유에 바이오테크 디벨롭먼트 컴퍼니 리미티드 보체 인자 b 억제제 및 이의 약학적 조성물, 제조 방법 및 용도
AU2021414253B2 (en) * 2020-12-30 2024-05-16 Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. Series of piperidine-substituted benzoic acid compounds, and use thereof
CA3203320A1 (en) * 2020-12-30 2022-07-07 Xin Li Nitrogen-containing bridged heterocyclic compound, preparation method therefor, and medical use thereof
MX2023013148A (es) * 2021-05-07 2023-11-28 Novartis Ag Iptacopan para el tratamiento del sindrome uremico hemolitico atipico.
EP4389742A4 (en) * 2021-08-18 2026-01-14 Xizang Haisco Pharmaceutical Co Ltd HETEROAROMATIC CYCLE DERIVATIVE CONTAINING BENZO NITROGEN AND ITS USE IN MEDICINE
TW202334121A (zh) * 2021-10-27 2023-09-01 美商翰森生物有限責任公司 哌啶基吲哚衍生物、其製備方法及醫藥用途
CA3247772A1 (en) * 2022-01-24 2023-07-27 Novartis Ag Spirocyclic piperidinyl derivatives as complement factor B inhibitors and their uses
WO2023143293A1 (zh) * 2022-01-26 2023-08-03 上海美悦生物科技发展有限公司 补体因子b抑制剂的盐型、晶型及其制备方法和应用
CN119343347A (zh) * 2022-06-10 2025-01-21 正大天晴药业集团股份有限公司 双环取代的芳香羧酸酯类化合物
WO2023246677A1 (zh) * 2022-06-20 2023-12-28 深圳信立泰药业股份有限公司 一种吲哚-苯基哌啶化合物及其制备方法与应用
JP7849520B2 (ja) 2022-06-30 2026-04-21 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 含窒素架橋複素環誘導体の薬学的に許容される塩、結晶形及びその調製方法
CN117327070A (zh) * 2022-06-30 2024-01-02 江苏恒瑞医药股份有限公司 一种含氮桥杂环衍生物的晶型及其制备方法
CA3266935A1 (en) * 2022-09-10 2024-03-14 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Piperidine derivatives substituted at position 2, their preparation methods and medicinal uses
JP2025541667A (ja) * 2022-11-11 2025-12-23 シャンハイ イーシェン バイオファーマシューティカル カンパニー リミテッド ピペリジン置換安息香酸系化合物、その医薬組成物および使用
WO2024141011A1 (zh) * 2022-12-31 2024-07-04 深圳晶泰科技有限公司 补体因子b抑制剂及其药物组合物和应用
CN119371402A (zh) * 2023-07-26 2025-01-28 上海美悦生物科技发展有限公司 螺环烯基类或氮杂烯基类化合物及其药物组合物、制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192742B2 (en) * 2007-03-23 2012-06-05 NovelMed Therapeutics Method of inhibiting complement activation with human anti-factor C3 antibodies and use thereof
WO2014002058A2 (en) 2012-06-28 2014-01-03 Novartis Ag Complement pathway modulators and uses thereof
US9475806B2 (en) * 2013-03-14 2016-10-25 Novartis Ag Complement factor B inhibitors and uses there of
JO3425B1 (ar) * 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
KR20180091097A (ko) * 2015-12-23 2018-08-14 그리노파티온 바이오테크 게엠베하 보체 활성화를 억제하기 위한 폴리펩티드
KR102528260B1 (ko) * 2016-01-05 2023-05-04 유니버시티 오브 레스터 필요로 하는 대상체에서 섬유증의 억제 방법
RS66635B1 (sr) 2017-08-31 2025-04-30 Novartis Ag Derivati piperidinil-indola za upotrebu u lečenju c3 glomerulopatije
CN120208923A (zh) 2020-05-18 2025-06-27 诺华股份有限公司 Lnp023的结晶形式
US11951101B2 (en) 2020-07-16 2024-04-09 Novartis Ag Methods of using factor B inhibitors

Also Published As

Publication number Publication date
AU2018326768B2 (en) 2021-07-29
CN117338782A (zh) 2024-01-05
HRP20251596T1 (hr) 2026-01-30
KR102497487B1 (ko) 2023-02-08
FI3675854T3 (fi) 2025-04-07
JP2020193222A (ja) 2020-12-03
US20200338059A1 (en) 2020-10-29
PT3675854T (pt) 2025-04-04
WO2019043609A1 (en) 2019-03-07
JP6754919B1 (ja) 2020-09-16
CN117338783A (zh) 2024-01-05
IL272888B2 (en) 2024-01-01
EP4393545A2 (en) 2024-07-03
CL2020000483A1 (es) 2020-09-04
ES3022885T3 (en) 2025-05-29
EP4647121A3 (en) 2026-02-18
CN117398384A (zh) 2024-01-16
PT4393545T (pt) 2025-12-23
RU2020111788A3 (da) 2021-12-28
RU2020111788A (ru) 2021-09-30
KR20200047540A (ko) 2020-05-07
US20250195493A1 (en) 2025-06-19
JP7297016B2 (ja) 2023-06-23
CN111032042A (zh) 2020-04-17
HRP20250386T1 (hr) 2025-05-23
EP3675854B1 (en) 2025-01-22
US11723901B2 (en) 2023-08-15
EP4393545B1 (en) 2025-10-08
PL3675854T3 (pl) 2025-05-19
US12285422B2 (en) 2025-04-29
CA3073346A1 (en) 2019-03-07
BR112020003737A2 (pt) 2020-09-01
KR102682887B1 (ko) 2024-07-08
ES3058507T3 (en) 2026-03-11
DK3675854T3 (da) 2025-04-07
PL4393545T3 (pl) 2026-03-16
KR20240111007A (ko) 2024-07-16
MX2023010751A (es) 2023-09-20
KR20230024432A (ko) 2023-02-20
MX2020002185A (es) 2020-07-14
EP4647121A2 (en) 2025-11-12
SI4393545T1 (sl) 2026-02-27
JP2021181471A (ja) 2021-11-25
IL272888A (en) 2020-04-30
FI4393545T3 (fi) 2026-01-14
HUE071118T2 (hu) 2025-08-28
CN117338781A (zh) 2024-01-05
MX2023010750A (es) 2023-09-20
JP6929425B2 (ja) 2021-09-01
RS67530B1 (sr) 2026-01-30
JP2020529466A (ja) 2020-10-08
RS66635B1 (sr) 2025-04-30
SI3675854T1 (sl) 2025-05-30
US20220152011A1 (en) 2022-05-19
IL272888B1 (en) 2023-09-01
LT4393545T (lt) 2026-01-12
LT3675854T (lt) 2025-04-25
EP3675854A1 (en) 2020-07-08
EP4393545A3 (en) 2024-09-25
AU2018326768A1 (en) 2020-02-06

Similar Documents

Publication Publication Date Title
DK4393545T3 (da) Hidtil ukendte anvendelser af piperidinyl-indolderivater
EP3496717A4 (en) 4-substituted aminoisoquinoline derivatives
DK3515297T3 (da) Biosymmetrisk sammenligning af subepidermale fugtværdier
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
DK3509581T3 (da) Formuleringer af (r)-2-amino-3-phenylpropylcarbamat
EP3436004C0 (en) SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRUS INHIBITORS
DK3204378T3 (da) N-pyridinylacetamidderivater som hæmmere af wnt-signaleringsbanen
LT3436437T (lt) Pakeistieji indolo dariniai kaip dengės viruso replikacijos inhibitoriai
IL265166B (en) Anti-influenza virus pyrimidine derivatives
DK3630724T3 (da) Substituerede indolinderivater som inhibitorer af virusreplikation af denguevirus
DK3448846T3 (da) Syntese af indazoler
PL3625224T3 (pl) Pochodne n-podstawionego indolu
DK3551625T3 (da) Heterocykliske inhibitorer af mct4
PL3457851T3 (pl) Pochodne sobetiromu
JOP20170120A1 (ar) مشتقات اندول حلقية ضخمة
IL272851A (en) Methods of using dipivefrin
EP3684772C0 (en) CYCLIC IMINOPYRIMIDINE DERIVATIVES AS KINASE INHIBITORS
LT3402792T (lt) Chinolin-2-ono dariniai
DK3448849T3 (da) Syntese af indazoler
DK3371168T3 (da) Indolin-2-on-derivater
DK3474822T3 (da) Formuleringer af brincidofovir
DK3418273T3 (da) Derivater af flavagliner
PL3898637T3 (pl) Pochodne rapamycyny